What CME (CME) Investors Need to Know Today

CME logged a 5.42% change during today's premarket session, and is now trading at a price of $187.43 per share. On average, analysts give it a target price of $200.82.

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. If you are thinking buying CME should be aware of the facts below:

  • Based on its trailing earning per share of 7.33, CME has a trailing 12 month Price to Earnings (P/E) ratio of 25.57

  • CME has a forward P/E ratio of 21.83.

  • The company has a price to earnings growth (PEG) ratio of 4.693 — a number between 0 and 1 signifying that CME is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 2.277

  • The large-cap company is based in the United States. CME currently returns an annual dividend yield of 4.84%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.